About SequenceBase and USGENE^®

USGENE^® provides searchable access to all available peptide and nucleotide sequences from the published applications and issued patents of the United States Patent and Trademark Office (USPTO). U.S. patent sequence data are available in USGENE within only 3 days of publication by the USPTO.

With an archive dating back to 1982, and a timeliness of within 3 days of USPTO publication, USGENE is the unparalleled resource in which to perform freedom-to-operate, prior art, validity and infringement patent sequence searches in U.S. gene patent publications.

USGENE database records contain sequence and related bioinformatics data, including organism name, sequence length and feature tables for modifications and other features. Extensive bibliographic and text search options, including publication title, abstract, legal claims, patent assignees at issue, full inventor names, plus the complete set of publication, application and parent case international WIPO/PCT numbers and dates are also provided.

USGENE data are available for customized subscription download, to suit various in-house molecular biology patent information needs, or can be searched online via the world’s premier Sci-Tech online information service STN^® International.

A summary of USGENE coverage and an annotated sample record are available.

Please fill out the Contact form if you have further questions about USGENE, content or coverage. Someone from our organization will contact you shortly.

About the SequenceBase Corporation
The SequenceBase Corporation is a leader in providing patent sequence information to the biotech, legal, pharmaceutical, scientific, technical and academic bioinformatics communities. USGENE is our unparalleled resource for freedom-to-operate, validity, infringement and prior-art intellectual property sequence searches, competitive analysis of organizations with gene patent publications, and current awareness alerts (SDIs) from the very latest USPTO polypeptide, DNA and RNA sequence data. In addition to producing USGENE on STN^®, we provide customized subscription download services of USGENE data to a wide variety of clients, in multiple standard formats to suit their in-house molecular biology patent information needs.

Our President and CEO
Dr. Martin Goffman, President, Chief Executive Officer and founder of SequenceBase Corporation holds a Ph.D. in Chemistry from Temple University and has owned and operated small high technology businesses for the past 20 years. In addition to his involvement in the SequenceBase Corporation, Dr. Goffman is also a co-founder of StockPricePredictor.com, LLC. Dr. Goffman maintains his long time passion of information research, particularly in the patent information and related technology fields, and he is the principal of Martin Goffman Associates. See www.goffman.com for more information about Dr. Goffman.